Do you or your loved one have Alzheimer’s disease?

Consider the ROAD clinical research study as the next stop on your journey.

If you, or a loved one, have been diagnosed with Alzheimer’s disease, you may be eligible for a study that will look at the safety and effectiveness of a possible new drug for treating Alzheimer’s disease. Participants must be between 50 to 85 years of age, and have a reliable caregiver. Additional criteria will be required for participation.

Eligible participants will receive:

• Potential access to a study drug at no charge
• Opportunity to participate in an open-label period during which all participants will receive the study drug
• Study-related support and monitoring by a healthcare team
• Education about Alzheimer’s disease

To see if you are eligible to participate in the ROAD study, contact Meridien Research at 352-597-8839.